Lepidi S, Piazza M, Scrivere P, Menegolo M, Antonello M, Grego F, Frigatti P
Department of Cardiac, Thoracic and Vascular Sciences, Division of Vascular and Endovascular Surgery, University of Padova, Padova, Italy.
Department of Cardiac, Thoracic and Vascular Sciences, Division of Vascular and Endovascular Surgery, University of Padova, Padova, Italy.
Eur J Vasc Endovasc Surg. 2014 Jul;48(1):29-37. doi: 10.1016/j.ejvs.2014.03.017. Epub 2014 May 17.
Endovascular treatment of distal abdominal aortic aneurysms (D-AAA) and bilateral common iliac artery aneurysms (BCIAA) may present technical challenges for standard EVAR. Parallel iliac leg endografts (ILEs) of standard aortic devices and covered stents have been successfully employed to treat patients with D-AAA and BCIAA. The perioperative and long-term results of this straightforward endovascular technique are presented.
Beginning in 2009, patients deemed unfit for open surgery underwent parallel endografts D-AAA and BCIAA exclusion. Avoiding the use of a main body, ILEs are simultaneously delivered from both femoral arteries, landing parallel into the aortic neck (parallel grafts: PG). Distal landing zones including external iliac arteries (EIAs) are reached using appropriate ILEs. A third parallel covered stent graft (Viabahn, Gore) is delivered from a left brachial approach to maintain prograde blood flow to one internal iliac artery (IIA) when needed.
Eighteen patients were successfully treated using parallel endografts, nine for BCIAA and nine for D-AAA. All D-AAA presented an irregular saccular shape, including three penetrating aortic ulcers and two pseudoaneurysms of previous aortic grafts. Prograde flow to one IIA was successfully maintained using a Viabahn graft in five patients with BCIAA. Mean aneurysm size was 50 mm in D-AAA and 43 mm in BCIAA. One patient required a perioperative ILE extension to treat a type Ib endoleak. One patient suffered a minor stroke 24 hours after the procedure. Two type II endoleaks were observed postoperatively. Five patients died of non-aneurysm related causes during follow-up. No new endoleaks, graft displacements or occlusions were observed during follow-up (median: 26 months, range 12-42 months).
Successful exclusion of D-AAA and BCIAA was achieved in high-risk patients using parallel endografts, allowing antegrade blood flow to one IIA when needed. Commercially available endografts were used in a simple and effective approach, with excellent follow-up results.
腹主动脉远端动脉瘤(D-AAA)和双侧髂总动脉瘤(BCIAA)的血管内治疗对标准的腔内血管修复术(EVAR)而言可能存在技术挑战。标准主动脉装置的平行髂支腔内移植物(ILE)和覆膜支架已成功用于治疗D-AAA和BCIAA患者。本文介绍了这种直接的血管内技术的围手术期和长期结果。
从2009年开始,被认为不适合开放手术的患者接受了平行腔内移植物治疗D-AAA和BCIAA。不使用主体移植物,ILE从双侧股动脉同时输送,平行锚定在主动脉颈部(平行移植物:PG)。使用合适的ILE到达包括髂外动脉(EIA)在内的远端锚定区。当需要时,通过左肱动脉途径输送第三个平行覆膜支架移植物(Viabahn,戈尔公司),以维持一侧髂内动脉(IIA)的顺行血流。
18例患者成功接受了平行腔内移植物治疗,其中9例为BCIAA,9例为D-AAA。所有D-AAA均呈现不规则囊状形态,包括3例穿透性主动脉溃疡和2例既往主动脉移植物假性动脉瘤。5例BCIAA患者使用Viabahn移植物成功维持了一侧IIA的顺行血流。D-AAA的平均动脉瘤大小为50mm,BCIAA为43mm。1例患者围手术期需要延长ILE以治疗Ib型内漏。1例患者术后24小时发生轻度中风。术后观察到2例II型内漏。5例患者在随访期间死于非动脉瘤相关原因。随访期间未观察到新的内漏、移植物移位或闭塞(中位时间:26个月,范围12 - 42个月)。
使用平行腔内移植物在高危患者中成功排除了D-AAA和BCIAA,必要时可使血流顺行至一侧IIA。采用市售腔内移植物的方法简单有效,随访结果良好。